A valid prescription requires a telehealth consultation with a licensed provider. No medication is dispensed without clinical evaluation.

Tesamorelin 4mg/mL
Targeted Visceral Adipose & GHRH Analog


Compound Specifications
Tesamorelin 4mg/mL
Targeted Visceral Adipose & GHRH Analog
Synthetic growth hormone-releasing hormone (GHRH) analog clinically recognized for targeting deep, stubborn visceral adipose tissue surrounding abdominal organs while supporting cognitive focus.
Binds to pituitary GHRH receptors, prompting pulsatile GH release that preferentially stimulates lipolysis of deep visceral abdominal fat beds.
Documented Therapeutic Benefits
Results may vary. Individual outcomes depend on adherence, baseline health, and other factors.
Administer subcutaneously once daily before bed.
Frequently Asked Clinical Questions
How does Tesamorelin target visceral fat?
Visceral fat cells have higher density of GH receptors, making them exceptionally responsive to Tesamorelin-mediated GH pulses.
